NYSE:INSP - Inspire Medical Systems Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $173.70
  • Forecasted Upside: -2.81 %
  • Number of Analysts: 9
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$178.72
▲ +1.97 (1.11%)

This chart shows the closing price for INSP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Inspire Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for INSP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for INSP

Analyst Price Target is $173.70
▼ -2.81% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for Inspire Medical Systems in the last 3 months. The average price target is $173.70, with a high forecast of $275.00 and a low forecast of $50.00. The average price target represents a -2.81% upside from the last price of $178.72.

This chart shows the closing price for INSP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 9 investment analysts is to buy stock in Inspire Medical Systems. This rating has held steady since January 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/20/2021Piper SandlerLower Price TargetOverweight$235.00 ➝ $215.00High
7/14/2021Piper SandlerLower Price TargetOverweight ➝ Overweight$255.00 ➝ $235.00High
6/23/2021SVB LeerinkReiterated RatingBuyMedium
5/25/2021SVB LeerinkReiterated RatingBuyMedium
5/5/2021Lake Street CapitalBoost Price TargetBuy$250.00 ➝ $260.00High
5/5/2021Piper SandlerBoost Price TargetPositive ➝ Overweight$252.00 ➝ $255.00High
4/25/2021Robert W. BairdReiterated RatingBuyHigh
2/24/2021Piper SandlerBoost Price TargetOverweight$210.00 ➝ $252.00Medium
2/24/2021Lake Street CapitalBoost Price TargetBuy$215.00 ➝ $250.00Low
2/24/2021SVB LeerinkBoost Price TargetOutperform$225.00 ➝ $275.00High
1/7/2021Lake Street CapitalBoost Price TargetBuy$150.00 ➝ $215.00Low
1/4/2021Bank of AmericaDowngradeBuy ➝ NeutralN/A
12/15/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$162.00 ➝ $209.00Low
12/3/2020Piper SandlerBoost Price TargetOverweight$147.00 ➝ $210.00Medium
11/3/2020Wells Fargo & CompanyBoost Price TargetOverweight$135.00 ➝ $140.00High
11/3/2020SVB LeerinkBoost Price TargetOutperform$150.00 ➝ $170.00High
11/3/2020Robert W. BairdBoost Price TargetOutperform$130.00 ➝ $160.00High
11/3/2020Bank of AmericaUpgradeNeutral ➝ Buy$125.00 ➝ $155.00High
11/3/2020Piper SandlerBoost Price TargetOverweight$137.00 ➝ $147.00High
11/3/2020OppenheimerUpgradeUnderperform ➝ Market PerformHigh
9/22/2020JPMorgan Chase & Co.Initiated CoverageOverweight$148.00High
9/18/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$116.00 ➝ $137.00High
9/10/2020Wells Fargo & CompanyBoost Price TargetOverweight$125.00 ➝ $135.00Medium
9/9/2020SVB LeerinkBoost Price TargetPositive ➝ Outperform$120.00 ➝ $150.00High
9/1/2020Robert W. BairdInitiated CoverageOutperform$130.00Low
8/21/2020Stifel NicolausBoost Price Target$110.00 ➝ $125.00Low
8/6/2020Wells Fargo & CompanyBoost Price TargetPositive ➝ Overweight$115.00 ➝ $125.00Medium
8/6/2020Bank of AmericaDowngradeBuy ➝ Neutral$115.00High
8/5/2020Piper SandlerBoost Price Target$98.00 ➝ $111.00Low
8/5/2020SVB LeerinkBoost Price TargetOutperform$110.00 ➝ $120.00High
8/5/2020Lake Street CapitalBoost Price TargetBuy$100.00 ➝ $130.00High
8/5/2020OppenheimerReiterated RatingSell$42.00 ➝ $50.00High
7/15/2020The Goldman Sachs GroupInitiated CoverageBuy$148.00High
6/29/2020SVB LeerinkBoost Price TargetOutperform$85.00 ➝ $110.00Low
6/18/2020Piper SandlerBoost Price TargetOverweight$81.00 ➝ $98.00Medium
5/26/2020Wells Fargo & CompanyBoost Price TargetOverweight$81.00 ➝ $95.00High
5/18/2020Lake Street CapitalInitiated CoverageBuy$90.00High
5/6/2020GuggenheimBoost Price TargetBuy$80.00 ➝ $90.00High
5/6/2020OppenheimerInitiated CoverageSell$42.00High
4/28/2020Bank of AmericaUpgradeNeutral ➝ Buy$90.00High
4/19/2020Piper SandlerInitiated CoverageOverweight$74.00Medium
4/15/2020Stifel NicolausBoost Price TargetBuy$88.00 ➝ $95.00Low
4/9/2020Piper SandlerInitiated CoverageOverweight$74.00High
4/2/2020OppenheimerLower Price Target$50.00 ➝ $42.00Medium
2/26/2020Bank of AmericaBoost Price TargetNeutral$75.00 ➝ $85.00High
2/26/2020Stifel NicolausBoost Price TargetBuy$82.00 ➝ $88.00High
2/26/2020SVB LeerinkBoost Price TargetOutperform$75.00 ➝ $97.00High
2/26/2020Wells Fargo & CompanyBoost Price TargetOverweight$90.00 ➝ $93.00High
1/27/2020OppenheimerInitiated CoverageUnderperform$50.00High
1/16/2020Wells Fargo & CompanyBoost Price TargetOverweight$70.00 ➝ $90.00High
11/6/2019Berenberg BankUpgradeSell ➝ Hold$46.00 ➝ $51.00High
9/27/2019Dougherty & CoSet Price TargetBuy$78.00High
7/8/2019Bank of AmericaReiterated RatingPositive ➝ Neutral$65.00 ➝ $75.00Low
2/5/2019Dougherty & CoInitiated CoverageBuy ➝ Buy$64.00High
11/28/2018Berenberg BankInitiated CoverageSell ➝ Sell$31.00High
10/29/2018SVB LeerinkInitiated CoverageOutperform ➝ Outperform$57.00High
5/29/2018Wells Fargo & CompanyInitiated CoverageOutperform$38.00High
5/29/2018Bank of AmericaInitiated CoverageNeutral$36.00High
5/29/2018GuggenheimInitiated CoverageBuy$40.00High
5/29/2018The Goldman Sachs GroupInitiated CoverageNeutral$25.00High
5/29/2018Stifel NicolausInitiated CoverageBuy$42.00High
(Data available from 7/24/2016 forward)
Inspire Medical Systems logo
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Read More

Today's Range

Now: $178.72
Low: $174.54
High: $178.99

50 Day Range

MA: $183.84
Low: $164.93
High: $201.82

52 Week Range

Now: $178.72
Low: $97.19
High: $252.25

Volume

136,702 shs

Average Volume

245,107 shs

Market Capitalization

$4.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65

Frequently Asked Questions

What sell-side analysts currently cover shares of Inspire Medical Systems?

The following Wall Street sell-side analysts have issued research reports on Inspire Medical Systems in the last twelve months: Bank of America Co., JPMorgan Chase & Co., Lake Street Capital, Oppenheimer Holdings Inc., Piper Sandler, Robert W. Baird, Stifel Nicolaus, SVB Leerink LLC, The Goldman Sachs Group, Inc., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for INSP.

What is the current price target for Inspire Medical Systems?

10 Wall Street analysts have set twelve-month price targets for Inspire Medical Systems in the last year. Their average twelve-month price target is $173.70, suggesting a possible downside of 2.8%. SVB Leerink LLC has the highest price target set, predicting INSP will reach $275.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $50.00 for Inspire Medical Systems in the next year.
View the latest price targets for INSP.

What is the current consensus analyst rating for Inspire Medical Systems?

Inspire Medical Systems currently has 3 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe INSP will outperform the market and that investors should add to their positions of Inspire Medical Systems.
View the latest ratings for INSP.

What other companies compete with Inspire Medical Systems?

How do I contact Inspire Medical Systems' investor relations team?

Inspire Medical Systems' physical mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The company's listed phone number is 844-672-4357 and its investor relations email address is [email protected] The official website for Inspire Medical Systems is www.inspiresleep.com.